Photoimmunotherapy targeting HER2 using affibody-based vectors
2015/19/N/NZ7/01336
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski
Voivodeship: dolnośląskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 10 – announced on 2015-09-15
- Amount awarded
- 145 200 PLN
- Project start date
- 2016-09-05
- Project end date
- 2020-09-04
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Immunomodulatory activity of IR700-labelled affibody targeting HER2
- Authors:
- Justyna Mączyńska, Chiara Da Pieve, Thomas A. Burley Burley, Florian Raes, Anant Shah, Jolanta Saczko, Kevin Harrington, Gabriela Kramer-Marek
- Academic press:
- Cell Death & Disease (year: 2020, volume: 11, pages: 886), Publisher: Springer Nature
- Status:
- Published
- DOI:
- 10.1038/s41419-020-03077-6 – link to the publication